We are live on ! Find out more
WINT

Windtree Therapeutics Inc

Delisted

WINT was delisted on the 4th of May, 2017.

3 hedge funds and large institutions have $41K invested in Windtree Therapeutics Inc in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 33 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

65% less capital invested

Capital invested by funds: $116K → $41K (-$75K)

Holders
3
Holders Change
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

WINT Hedge Fund Activity: Q3 2017 in Review

3 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q3 2017, worth a combined $41K — down 65% from $116K a quarter earlier.

Fund positioning in WINT was balanced in Q3 2017: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was Panagora Asset Management, opening a new position worth an estimated $37K. The largest seller was Sabby Management, exiting entirely with an estimated $112K sold.

  • 3 institutional investors held Windtree Therapeutics Inc (WINT) as of Q3 2017, unchanged from Q2 2017.
  • Funds reported $41K of Windtree Therapeutics Inc stock for Q3 2017, down 65% quarter-over-quarter.
  • 2 funds opened new Windtree Therapeutics Inc positions in Q3 2017 and 2 closed out, a net change of 0 holders.
  • The largest Windtree Therapeutics Inc buyer in Q3 2017 was Panagora Asset Management, an estimated $37K added.
  • The largest Windtree Therapeutics Inc seller in Q3 2017 was Sabby Management, an estimated $112K sold.

Based on aggregated 13F filings for Q3 2017.